Brady, Keri J. S. http://orcid.org/0000-0001-6417-0840
Peipert, John Devin http://orcid.org/0000-0001-5762-7881
Atkinson, Thomas M. http://orcid.org/0000-0002-4965-3913
Pompili, Cecilia http://orcid.org/0000-0001-6746-5441
Pinto, Monica http://orcid.org/0000-0002-0823-4907
Shaw, James W. http://orcid.org/0000-0002-7019-3720
Roydhouse, Jessica http://orcid.org/0000-0002-8025-5841
,
Funding for this research was provided by:
Select Foundation
National Institutes of Health (P30 CA008748)
University of Tasmania
Article History
Accepted: 8 March 2023
First Online: 23 May 2023
Declarations
:
: Jessica Roydhouse reports personal fees from Amgen and consultancy with the University of Birmingham Enterprise, outside the submitted work. Keri J. S. Brady reports employment with Sanofi. James W. Shaw reports employment with Bristol Myers Squibb. Monica Pinto reports personal fees from Meeting and Words S.r.l. and Hinovia S.r.l., and participation as Co-investigator in a study funded by Amgen, outside the submitted work. Cecilia Pompili reports consultancy with Astrazeneca, outside the submitted work.
: This is a commentary that did not involve human or animal participants, and as such ethics approval was not required.
: Not applicable.
: Not applicable.